Bio-Rad Laboratories News

RBC Capital Reaffirms Their Buy Rating on Bio-Rad Laboratories (BIO)

TipRanksApr 8 21:46 ET

RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating

MT NewswiresApr 8 07:43 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaApr 3 10:22 ET

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Bio-Rad Laboratories (BIO)

TipRanksMar 1 06:30 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaFeb 16 12:15 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO), Ultragenyx Pharmaceutical (RARE) and West Pharmaceutical Services (WST)

TipRanksFeb 16 08:40 ET

RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating

MT NewswiresFeb 16 07:53 ET

Bio-Rad Laboratories (BIO) Receives a Buy From RBC Capital

TipRanksFeb 16 07:38 ET

Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Bio-Rad Laboratories (BIO)

TipRanksFeb 16 07:10 ET

RBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)

TipRanksJan 26 20:45 ET

UBS Initiates Coverage On Bio-Rad Laboratories With Buy Rating, Announces Price Target of $395

BenzingaDec 7, 2023 06:10 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaDec 7, 2023 06:09 ET

Analysts Offer Insights on Healthcare Companies: Alimera (ALIM), Bio-Rad Laboratories (BIO) and PTC Therapeutics (PTCT)

TipRanksOct 27, 2023 06:41 ET

Analysts Offer Insights on Healthcare Companies: Bio-Rad Laboratories (BIO), Biogen (BIIB) and REPRO-MED Systems (KRMD)

TipRanksOct 19, 2023 09:02 ET

Bio-Rad Laboratories (BIO) Receives a Buy From RBC Capital

TipRanksAug 29, 2023 21:45 ET

Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Lowers Price Target to $525

BenzingaAug 7, 2023 08:05 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaAug 7, 2023 08:04 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaAug 4, 2023 09:29 ET

RBC Raises Price Target on Bio-Rad Laboratories to $524 From $522, Maintains Outperform Rating

MT NewswiresAug 4, 2023 07:39 ET

RBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)

TipRanksJul 18, 2023 21:46 ET